ALNY

Alnylam Pharmaceuticals, Inc. (ALNY)

Last Price$238.0(1.1%)
Market Cap$30.1B
LTM Free Cash Flow margin
0.8%
5Y avg
(90.2%)
Biotechnology industry median
(753.4%)
Stock quality & Intrinsic value
6/10
(0.6%) overvalued

Alnylam Pharmaceuticals, Inc. Free Cash Flow margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
ALNY
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Free Cash Flow margin
(668.0%)
(322.5%)
(110.0%)
370.8%
56.9%
(76.7%)
(89.0%)
(106.8%)
(185.8%)
(154.1%)
(345.3%)
(491.7%)
(789.4%)
(541.6%)
(920.5%)
(190.5%)
(139.1%)
(85.0%)
(59.1%)
2.3%
ALNY
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ALNY and see if it's the right time to invest.
Dive in

Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

ALNY key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Alnylam Pharmaceuticals, Inc.'s Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 0.8%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for Alnylam Pharmaceuticals, Inc. have been (49.4%) over the past three years, and (94.7%) over the past five years.

2) Is Alnylam Pharmaceuticals, Inc.'s Free Cash Flow margin Good?

As of today, Alnylam Pharmaceuticals, Inc.'s Free Cash Flow margin is 0.8%, which is higher than industry median of (753.4%). It indicates that Alnylam Pharmaceuticals, Inc.'s Free Cash Flow margin is Good.

3) How does Alnylam Pharmaceuticals, Inc.'s Free Cash Flow margin compare to its peers?

As of today, Alnylam Pharmaceuticals, Inc.'s Free Cash Flow margin is 0.8%, which is lower than peer median of 12.4%. The list of peers includes GMAB, UTHR, BNTX, NVO, REGN, INCY, ARGX, VRTX, BGNE, MRNA.